Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)
Clinical trial NCT05722795 · RECRUITING
Trial details
- NCT number
- NCT05722795
- Sponsor
- Vastra Gotaland Region
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2029-06-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.